Givinostat
Commons · Question 38494 · Tabled 14 Mar 2025 · Department of Health and Social Care · Official record
Answered 26 Mar 2025
Question
Asked by Neil Shastri-Hurst
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with (a) NHS England and (b) ITF Pharma UK to ensure that NHS Trusts have the necessary resources and guidance to take part in the Early Access Programme for
Answer
Answered by Karin Smyth, 26 Mar 2025
The Department understands the impact that Duchenne muscular dystrophy has on those living with it and their families, and the urgent need for new treatment options. The National Institute for Health and Care Excellence (NICE) recently published guidance ...